Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Nenad Prodanovic"'
Autor:
Wieslawa Porawska, Younju Lee, Jung-Yoon Choe, Josef S Smolen, Krystyna Jedrychowicz-Rosiak, Young Hee Rho, Mevludin Mekic, Nenad Prodanovic, Hana Ciferska, Agnieszka Zielińska, Eva Dokoupilova, Asta Baranauskaite, Ivan Staykov, Jaroslaw Niebrzydowski, Roman Yatsyshyn
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesEfficacy, safety and immunogenicity results from the phase III study of SB2, a biosimilar of reference infliximab (INF), were previously reported through 54 weeks. This transition period compared results in patients with rheumatoid arthriti
Autor:
Zoran Radojicic, Natasa Cvetinovic, Vera Popovic, Biljana Putnikovic, Biljana Bozic, Mitja Lainscak, Aleksandar N. Neskovic, Natasa Markovic-Nikolic, Goran Loncar, Nenad Prodanovic, Hans-Dirk Düngen, Stephan von Haehling, Tobias Daniel Trippel
Publikováno v:
The Aging Male. 20:215-224
We aimed at evaluating androgen status (serum testosterone [TT] and estimated free testosterone [eFT]) and its determinants in non-diabetic elderly men with heart failure (HF). Additionally, we investigated its associations with body composition and
Publikováno v:
Rheumatology international. 39(12)
Rheumatoid arthritis (RA) is an autoimmune disease causing chronic inflammation of the joints. Multiple factors, including HLA-DRB1 gene variants, influence the susceptibility to RA. The HLA-DRB1 gene is part of a family of genes called the human leu
Autor:
Sang Joon Lee, Dae Hyun Yoo, Won Park, Nenad Prodanovic, Edgar Ramiterre, Suyeon Kim, Svitlana Smiyan, Janusz Jaworski, HoUng Kim, Piotr Wiland, Carlos Abud-Mendoza, Allan Lanzon, Boycho A Oparanov, Pedro Miranda, Asta Baranauskaite
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo assess the efficacy and safety of switching from the infliximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing CT-P13 in patients with rheumatoid arthritis (RA) for an additional six infusion
Autor:
Jung-Yoon Choe, Asta Baranauskaite, Josef S Smolen, Eva Dokoupilova, Nenad Prodanovic, Hana Ciferska, Young Hee Rho, Wieskawa Porawska, Roman Yatsyshyn, Mevludin Mekic, Krystyna Jedrychowicz-Rosiak, J. Choi, Agnieszka Zielińska, Ivan Staykov, Jaroslaw Niebrzydowski
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo compare the efficacy, safety, immunogenicity and pharmacokinetics (PK) of SB2 to the infliximab reference product (INF) in patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate therapy.MethodsThis is a phase III
Autor:
M. Lainscak, D. Toncev, Biljana Bozic, Natasa Markovic-Nikolic, Goran Loncar, Biljana Putnikovic, Hans-Dirk Düngen, Natasa Cvetinovic, Vera Popovic, S. Von Haehling, Zoran Radojicic, Nenad Prodanovic
Publikováno v:
European Heart Journal. 38
Autor:
Roman Yatsyshyn, Eva Dokoupilova, Young Hee Rho, Jung-Yoon Choe, J. Choi, Asta Baranauskaite, Nenad Prodanovic, Krystyna Jedrychowicz-Rosiak, Jaroslaw Niebrzydowski, Ivan Staykov, Wieskawa Porawska, Mevludin Mekic, Hana Ciferska, Agnieszka Zielińska, Josef S Smolen
Publikováno v:
Rheumatology (Oxford, England)
Objectives SB2 is a biosimilar to the reference infliximab (INF). Similar efficacy, safety and immunogenicity between SB2 and INF up to 30 weeks were previously reported. This report investigates such clinical similarity up to 54 weeks, including str
Autor:
Zoran Radojicic, Biljana Bozic, Vera Popovic, Nenad Prodanovic, Stephan von Haehling, Sinisa Dimkovic, Mitja Lainscak, Hans-Dirk Düngen, Aleksandra Arandjelovic, Goran Loncar
Publikováno v:
European Journal of Internal Medicine. 24:818-823
Reduced peripheral muscle mass was demonstrated in patients with chronic heart failure (HF). Adipokines may have potent metabolic effects on skeletal muscle. The associations between adipokines, peripheral muscle mass, and muscle function have been p
Autor:
Omid Zamani, Luis Morales-Olazabal, Dae Hyun Yoo, Mariusz Piotrowski, Pedro Miranda, Nenad Prodanovic, Sergii Shevchuk, Michael L. Tee, HoUng Kim, Edgar Ramiterre, Sang Joon Lee, Renato Jimenez, Volodymyr Kovalenko, Won Park, Mauricio Abello-Banfi, Paweł Hrycaj, Ulf Müller-Ladner, Sergio Gutierrez-Ureña
Publikováno v:
Annals of the Rheumatic Diseases
Objectives To compare the efficacy and safety of innovator infliximab (INX) and CT-P13, an INX biosimilar, in active rheumatoid arthritis patients with inadequate response to methotrexate (MTX) treatment. Methods Phase III randomised, double-blind, m
Autor:
Vera Popovic-Brkic, Vojkan Cvorovic, Zoran Radojicic, Toplica Lepic, Milan Brajovic, Biljana Bozic, Nenad Prodanovic, Goran Loncar, Natasa Markovic, Nebojsa Despotovic, Sinisa Dimkovic, Biljana Putnikovic
Publikováno v:
The Aging Male. 14:59-65
Brain detrimental effects are under-recognised complication of chronic heart failure (CHF). One of the major causes may be cerebral hypoperfusion. This study was designed to investigate the relationship between cerebral blood flow (CBF) and severity